0,891  0,003  Caspase 9 stimulant
0,870  0,007  Antiinflammatory
0,762  0,007  Chemopreventive
0,762  0,012  Antineoplastic (lung cancer)
0,735  0,016  Antineoplastic (breast cancer)
0,735  0,025  Apoptosis agonist
0,697  0,008  Bone diseases treatment
0,692  0,014  Antileukemic
0,689  0,015  TNF expression inhibitor
0,682  0,011  Respiratory analeptic
0,659  0,007  Nitric oxide antagonist
0,643  0,008  Antipsoriatic
0,642  0,009  Antineoplastic (melanoma)
0,655  0,025  Transcription factor NF kappa B inhibitor
0,635  0,009  Antiosteoporotic
0,627  0,021  Antineoplastic (colorectal cancer)
0,623  0,020  Antineoplastic (colon cancer)
0,615  0,017  Prostate cancer treatment
0,597  0,011  Hepatic disorders treatment
0,567  0,014  Antineoplastic (pancreatic cancer)
0,538  0,022  Antineoplastic (ovarian cancer)
0,531  0,019  Analeptic
0,531  0,020  Cytotoxic
0,510  0,002  Antipruritic, non-allergic
0,522  0,026  Antipruritic, allergic
0,505  0,018  Antineoplastic (glioma)
0,503  0,020  Caspase 3 stimulant
0,490  0,010  Antineoplastic (liver cancer)
0,498  0,018  Antineoplastic (multiple myeloma)
0,497  0,020  Antineoplastic (brain cancer)
0,489  0,023  Sensitization
0,482  0,020  Proliferative diseases treatment
0,467  0,009  Hepatoprotectant
0,462  0,008  Abortion inducer
0,467  0,025  NOS3 expression inhibitor
0,457  0,015  Antineoplastic (osteosarcoma)
0,466  0,026  AR expression inhibitor
0,465  0,043  Immunosuppressant
0,441  0,020  Antineoplastic (lymphoma)
0,442  0,021  Antineoplastic (glioblastoma multiforme)
0,456  0,054  Antibacterial
0,410  0,010  Prostate disorders treatment
0,428  0,030  ICAM1 expression inhibitor
0,419  0,029  NOS2 expression inhibitor
0,400  0,011  Antiacne
0,399  0,011  Interferon gamma antagonist
0,409  0,029  UGT2B4 substrate
0,395  0,018  Sodium/bile acid cotransporter inhibitor
0,400  0,024  Antineoplastic (renal cancer)
0,401  0,024  Calcium channel activator
0,391  0,015  Contraceptive
0,372  0,015  Platelet adhesion inhibitor
0,380  0,039  Antioxidant
0,369  0,028  Vascular (periferal) disease treatment
0,375  0,035  Antiprotozoal (Leishmania)
0,386  0,049  Antifungal
0,364  0,034  Tumour necrosis factor alpha release inhibitor
0,358  0,030  Antineoplastic (endocrine cancer)
0,344  0,019  UGT2B7 substrate
0,348  0,026  UDP-glucuronosyltransferase substrate
0,367  0,047  Cardioprotectant
0,332  0,016  Hair growth stimulant
0,332  0,018  Prostatic (benign) hyperplasia treatment
0,306  0,005  Farnesoid X receptor antagonist
0,329  0,049  Chemoprotective
0,339  0,061  Apoptosis antagonist
0,262  0,004  Hypercalcemia treatment
0,309  0,055  Antineoplastic (cervical cancer)
0,290  0,038  Antineoplastic enhancer
0,286  0,035  Antihelmintic
0,290  0,046  Antiparasitic
0,250  0,009  Microtubule formation inhibitor
0,241  0,005  CDC25A inhibitor
0,239  0,023  UGT2B9 substrate
0,257  0,042  Growth hormone agonist
0,278  0,064  Antipyretic
0,246  0,032  Protein-tyrosine phosphatase inhibitor
0,234  0,021  Antifungal enhancer
0,299  0,088  Vasodilator, coronary
0,251  0,042  Non-steroidal antiinflammatory agent
0,234  0,029  Antiviral (Influenza A)
0,241  0,037  Lipocortins synthesis antagonist
0,236  0,033  Restenosis treatment
0,207  0,004  Opioid kappa receptor agonist
0,209  0,012  Contraceptive female
0,264  0,069  Embryotoxic
0,208  0,015  Choleretic
0,193  0,002  Na+ K+ transporting ATPase inhibitor
0,261  0,073  Antineoplastic (non-small cell lung cancer)
0,196  0,009  Inducible nitric-oxide synthase inhibitor
0,215  0,030  Antineoplastic (bone cancer)
0,220  0,035  Protein kinase stimulant
0,229  0,047  UGT1A4 substrate
0,252  0,071  Platelet antagonist
0,193  0,013  Pregnane X receptor agonist
0,246  0,072  Angiogenesis stimulant
0,184  0,011  ABCA1 expression enhancer
0,223  0,052  CYP2B6 inhibitor
0,170  0,002  Vitamin D receptor antagonist
0,175  0,008  Anabolic
0,185  0,022  Adenylate cyclase stimulant
0,213  0,054  Dual specificity phosphatase 3 inhibitor
0,195  0,038  Arachidonic acid antagonist
0,187  0,030  Cholesterol synthesis inhibitor
0,232  0,078  Antineoplastic (lymphocytic leukemia)
0,214  0,063  UGT1A1 substrate
0,166  0,016  Actinic keratosis treatment
0,207  0,059  P-glycoprotein inhibitor
0,182  0,034  Protein-tyrosine phosphatase 1B inhibitor
0,213  0,067  Antiviral (Influenza)
0,155  0,013  UGT2B11 substrate
0,142  0,002  Parathyroid hormone antagonist
0,187  0,048  UGT2B10 substrate
0,238  0,100  CYP2C19 substrate
0,165  0,028  Antineoplastic antibiotic
0,204  0,068  Carcinogenic
0,192  0,059  Dual specificity phosphatase inhibitor
0,148  0,016  Paget's disease treatment
0,252  0,124  Cholesterol antagonist
0,163  0,039  Antiviral (Hepatitis B)
0,212  0,089  Teratogen
0,139  0,018  Transcription factor NF kappa B stimulant
0,139  0,019  SULT1E1 substrate
0,122  0,004  Heme oxygenase stimulant
0,172  0,056  UGT2B15 substrate
0,204  0,089  Antiviral (HIV)
0,147  0,033  Constipation treatment
0,125  0,011  Narcotic antagonist
0,194  0,080  Pneumotoxic
0,265  0,152  Antineoplastic (myeloid leukemia)
0,136  0,027  Androgen antagonist
0,244  0,137  CYP3A4 substrate
0,118  0,011  Anticholelithogenic
0,265  0,159  CYP2C19 inhibitor
0,110  0,005  Postcoital contraceptive
0,122  0,017  Glycine receptor antagonist
0,120  0,021  Keratolytic
0,176  0,080  Antiviral (Hepatitis)
0,161  0,070  Antiviral (Herpes)
0,167  0,077  Antipruritic
0,134  0,046  Alcohol dehydrogenase substrate
0,105  0,018  Glycine receptor agonist
0,182  0,096  Neurotrophic factor enhancer
0,087  0,003  CYP24 inhibitor
0,150  0,068  Antidiabetic (type 1)
0,192  0,112  RNA-directed DNA polymerase inhibitor
0,099  0,022  Hyperparathyroidism treatment
0,086  0,011  Potassium channel Kv1.3 blocker
0,187  0,113  Antihypercholesterolemic
0,107  0,037  Bile acid receptor antagonist
0,132  0,063  Vanilloid 1 agonist
0,200  0,134  Transcription factor STAT3 inhibitor
0,216  0,152  Angiogenesis inhibitor
0,140  0,076  Antineoplastic (carcinoma)
0,084  0,022  Androgen agonist
0,229  0,168  CYP2C9 substrate
0,067  0,008  Farnesoid X receptor agonist
0,103  0,045  Thioredoxin inhibitor
0,072  0,015  Glucose-6-phosphate translocase inhibitor
0,060  0,003  Progesterone receptor B antagonist
0,145  0,088  Melanin inhibitor
0,072  0,020  Lipocortins synthesis agonist
0,073  0,022  Protease activated receptor 1 antagonist
0,126  0,076  Antihemorrhagic
0,115  0,065  Estrogen antagonist
0,075  0,026  Antimycoplasmal
0,108  0,059  Antiinfertility, female
0,110  0,062  Antiviral (SARS coronavirus)
0,110  0,062  Antiviral (Coronavirus)
0,124  0,079  Skin whitener
0,126  0,087  Antieczematic
0,113  0,074  DNA polymerase I inhibitor
0,134  0,097  UGT1A3 substrate
0,085  0,052  Opioid kappa receptor antagonist
0,047  0,014  RNA-directed RNA polymerase stimulant
0,097  0,065  Nitric-oxide synthase inhibitor
0,107  0,075  TRPA1 agonist
0,054  0,023  Microtubule stabilization
0,059  0,030  Opioid agonist
0,045  0,016  Glucose-6-phosphate dehydrogenase inhibitor
0,155  0,128  Antiulcerative
0,055  0,029  Anesthetic inhalation
0,094  0,070  Protease inhibitor
0,189  0,166  Hypoxia-inducible factor 1 alpha inhibitor
0,068  0,046  Leukotriene synthesis inhibitor
0,083  0,062  Vanilloid agonist
0,242  0,222  Cyclophilin D inhibitor
0,242  0,222  Antidiabetic
0,031  0,011  Retinoid X gamma receptor antagonist
0,123  0,103  Mutagenic
0,038  0,018  Tubulin agonist
0,171  0,152  Radioprotector
0,192  0,174  Immunomodulator
0,052  0,034  Estrogen agonist
0,057  0,038  Acetyl-CoA transferase 2 inhibitor
0,023  0,005  Vitamin D receptor agonist
0,125  0,108  Antidiarrheal
0,059  0,042  Aromatase inhibitor
0,104  0,091  Growth stimulant
0,123  0,110  NOS3 expression enhancer
0,112  0,099  Antineoplastic (squamous cell carcinoma)
0,069  0,058  Antibiotic
0,092  0,080  Estrogen receptor beta antagonist
0,037  0,026  5-Alpha-reductase inhibitor
0,089  0,079  Sulfotransferase substrate
0,034  0,025  Progesterone antagonist
0,051  0,043  Postmenopausal disorders treatment
0,109  0,100  Antimutagenic
0,009  0,002  Vitamin D-like
0,155  0,148  UGT1A6 substrate
0,021  0,015  Corticosteroid-like
0,139  0,133  Antimitotic
0,022  0,017  Retinoic acid gamma receptor agonist
0,025  0,022  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,068  0,065  Analgesic, opioid
0,021  0,019  Retinoid X gamma receptor agonist

